Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial
Gian Paolo Fadini,Benedetta Maria Bonora,Giancarlo Zatti…Volume:
16
Language:
english
Journal:
Cardiovascular Diabetology
DOI:
10.1186/s12933-017-0529-3
Date:
December, 2017
File:
PDF, 936 KB
english, 2017